Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02990533 · ClinicalTrials.gov registry record · Phase 1
Muscle Anabolic Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients
A Phase 1 study of Aging, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT02990533: Completed Phase 1 study of Aging, sponsored by The University of Texas Medical Branch, Galveston.
NCT02990533 is a Phase 1 study of Aging that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 80 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02990533, a Phase 1 study of Aging, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot study is to collect preliminary data on the feasibility and effect size of interventions to modify the physiological recovery trajectory from hospitalization in community dwelling older adults.
Primary Outcome
Short Physical Performance Battery (SPPB) scale, 0-12 points. 0=disabled; 12=high performance
Conditions Studied
Interventions
- DRUG Testosterone
- OTHER Placebo Injection
- DIETARY_SUPPLEMENT Protein Supplement
- OTHER Placebo supplement
Study Locations (1)
Texas
- Jennie Sealy Hospital - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-09 |
| Est. Completion | 2020-11-08 |
| Phase | Phase 1 |
What the finished NCT02990533 record still lists
NCT02990533 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 4 interventions - of which Testosterone is the first listed.
NCT02990533 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02990533 about?
NCT02990533 is a clinical study titled "Muscle Anabolic Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients". The goal of this pilot study is to collect preliminary data on the feasibility and effect size of interventions to modify the physiological recovery trajectory from hospitalization in community dwelling older adults.
What is the current status of trial NCT02990533?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2016-09. Estimated completion is 2020-11-08.
What conditions does trial NCT02990533 study?
This clinical trial studies the following conditions: Aging.
What interventions are being tested in trial NCT02990533?
The interventions under investigation include: Testosterone (DRUG), Placebo Injection (OTHER), Protein Supplement (DIETARY_SUPPLEMENT), Placebo supplement (OTHER).
Who is sponsoring clinical trial NCT02990533?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02990533 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02990533's enrollment target sits among peer trials
80 108th of 262 higher than 149 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of a Daily Supplement on Plasma PAI-1 Levels
RECRUITING · Phase 1
-
MTOR Inhibitors in Older Adults
RECRUITING · Phase 1
-
Rapalog Pharmacology (RAP PAC) Study
RECRUITING · Phase 1
-
Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults
RECRUITING · Phase 1
-
Fisetin to Improve Vascular Function in Older Adults
ACTIVE NOT RECRUITING · Phase 1
-
Wild Blueberries and Cardiovascular Health in Middle-aged/Older Men and Postmenopausal Women
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma